Loading Events
This event has passed.

Wednesday, May 17, 2023
12:00PM – 1:00PM Eastern Time

Register now

Webinar objectives:

  1. Describe methods to characterize the cervicovaginal microbiome (CVM)
  2. Detail the role of the CVM and HPV natural history
  3. Delineate the role of the CVM and acquisition of C. trachomatis infection


Robert D. Burk, M.D.
Professor, Department of Pediatrics (Pediatric Genetic Medicine), Professor, Department of Microbiology & Immunology, Professor, Department of Obstetrics & Gynecology and Women’s Health (Gynecological Oncology), Professor, Department of Epidemiology & Population Health (Epidemiology), Vice Chair for Translational Research Department of Pediatrics

Dr. Burk is a laboratory-based epidemiologist. He is currently investigating the role of the human microbiome and cervical HPV natural history and other STIs. Dr. Burk’s lab has pioneered the characterization of the cervicovaginal microbiome using next-generations sequencing. His lab has created an algorithm that takes next-generation sequencing (NGS) of 16S rRNA gene in clinical sample DNA and generates a Nugent-like bacterial vaginosis score (molBV). molBV thus allows clinical interpretation of NGS data and study of the cervicovaginal microbiome using stored DNA from HPV and/or other types of epidemiological studies. Dr. Burk is also an authority on the genomics and evolution of human papillomaviruses (HPV). His team was the first to report, in the New England Journal of
Medicine, that the vast majority of HPV infections in young women are short-lived and don’t require treatment. Dr. Burk is the past Chair of the HPV nomenclature group of the International Committee for the Taxonomy of Viruses (ICTV). He is an elected fellow of AAAS and has published over 450 peer-reviewed papers.


Dr. Marc Steben, M.D., C.C.F.P., F.C.F.P., D.E.S.S.
Family physician; President of IUSTI Canada and President elect International Society for STD Research

As a family physician, Marc concentrates his clinical interest on sexual health, mainly chronic genital diseases. Research, development and publications field include therapeutic approaches to chronic genital pain, prevention and treatment of genital herpes and development of HPV prophylactic vaccine. Marc is also President of IUSTI Canada.

Go to Top